While recall notices issued in Canada, Australia and Spain were broader based and included a list of 200 lots affected by the problems that caused injury. The Fairport, N.Y., firm has yet to heed a request from the FDA to broaden its notification of problems with the specific lots of the Avaira Toric contact lenses inside the US.
CooperVision officials did not respond to msnbc.com questions about why they had not complied with the FDA request. In a statement, a firm spokeswoman said that the company “has fully cooperated with the FDA and continues to closely monitor the situation and seek advice from FDA during this process.”
Critics say that CooperVision has downplayed the recall of hundreds of lots of contact lenses in the United States, exposing vulnerable consumers to ongoing injury.